← Eichor
Study identifier: NCT06659835 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Amino Acid Loss During Continuous Renal Replacement Therapy

Condition: Renal Insufficiency · Kidney Failure  ·  Sponsor: Medical University of Vienna

PhaseN/A
Planned participants30
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this observational study is to learn about amino acid loss during continuous renal replacement therapy and plasma amino acid levels in intensive care patients. The main questions it aims to answer are: What amount of amino acids is lost over the duration of continuous renal replacement therapy? How do amino acid plasma concentrations change over time in patients with and without continuous renal replacement therapy? Amino acid concentrations will be measured in the effluent and in the plasma of patients receiving continuous renal replacement therapy as part of their regular medical care. In addition, plasma concentrations of amino acids will be studied in patients without renal replacement therapy.

This description comes directly from the study's public registry record.

Talk to the study team

Sarah Yadavalli, Dr.  ·  +43 67761632558  ·  sarah.yadavalli@meduniwien.ac.at

Arabella Fischer, Dr.  ·  arabella.fischer@meduniwien.ac.at

Always discuss trial participation with your own doctor first.

Locations (1)

Medical University of ViennaVienna, State of Vienna, AustriaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06659835